Weibel_1987_J.Antibiot.(Tokyo)_40_1081

Reference

Title : Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity - Weibel_1987_J.Antibiot.(Tokyo)_40_1081
Author(s) : Weibel EK , Hadvary P , Hochuli E , Kupfer E , Lengsfeld H
Ref : J Antibiot (Tokyo) , 40 :1081 , 1987
Abstract :

Lipstatin, a new and very potent inhibitor of pancreatic lipase (the key enzyme of intestinal fat digestion) was isolated from Streptomyces toxytricini. Lipstatin contains a beta-lactone structure that probably accounts for the irreversible lipase inhibition. The IC50 of lipstatin for pancreatic lipase is 0.14 microM. In mice triolein absorption was dose-dependently inhibited by lipstatin, whereas oleic acid was absorbed normally. Other pancreatic enzymes, such as phospholipase A2 and trypsin, were not inhibited even at an inhibitor concentration of 200 microM.

PubMedSearch : Weibel_1987_J.Antibiot.(Tokyo)_40_1081
PubMedID: 3680018

Related information

Inhibitor Lipstatin

Citations formats

Weibel EK, Hadvary P, Hochuli E, Kupfer E, Lengsfeld H (1987)
Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity
J Antibiot (Tokyo) 40 :1081

Weibel EK, Hadvary P, Hochuli E, Kupfer E, Lengsfeld H (1987)
J Antibiot (Tokyo) 40 :1081